A 72-year-old man with long-standing atrial fibrillation on warfarin presents with melaena and Hb 78 g/L. After stabilisation and endoscopic therapy of a bleeding ulcer, when resuming anticoagulation for stroke prevention, which agent is preferred according to Canadian stroke and AF guidance?